Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults
Clinical trial NCT04672291 · COMPLETED
Trial details
- NCT number
- NCT04672291
- Sponsor
- Oncovir, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-21
- Primary completion
- 2023-04-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.